Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutationsIchidai Tanaka,Masahiro Morise,Yuta Kodama,Akira Matsui,Naoya Ozawa,Sachiko Ozone,Daiki Goto,Ayako Miyazawa,Tetsunari Hase,Naozumi Hashimoto,Mitsuo Sato,Yoshinori HasegawaLung Cancer(2019)引用 24|浏览37暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要